BALTIMORE, Aug. 29, 2023 /PRNewswire/ — MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) (“MIRA” or the “Company”), a pre-clinical-stage pharmaceutical company focused on the development and commercialization of a novel synthetic THC analog, will host a virtual roadshow webinar on Monday, September 11, 2023 at 1:00 p.m. Eastern Time. Erez Aminov, Chief…Read More
MIRA Pharmaceuticals to Host Virtual Roadshow Webinar on Monday September 11 2023 at 1 00 pm Eastern Time
